Recall Monitor
Health ProductsType I recall

APO-QUETIAPINE XR - May exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: APO-QUETIAPINE XR
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution: National
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct NameMarket AuthorizationDosage FormStrengthLot numbers
APOTEXAPO-QUETIAPINE XR 50mgDIN 02457229Tablet (Extended Release)Quetiapine fumarate 50mgM2213002, M2213003 & M2214445
APOTEXAPO-QUETIAPINE XR 200mgDIN 02457245Tablet (Extended Release)Quetiapine fumarate 200mgM2214011 & M2214015

Issue

Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime